BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G901. A total of 5 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,984,000 | -35.0% | 25,500 | -31.1% | 0.00% | -50.0% |
| Q1 2016 | $3,052,000 | -17.9% | 37,000 | +4.2% | 0.00% | 0.0% |
| Q4 2015 | $3,719,000 | +37.9% | 35,500 | +38.7% | 0.00% | +33.3% |
| Q3 2015 | $2,696,000 | -60.8% | 25,600 | -49.1% | 0.00% | -50.0% |
| Q2 2015 | $6,880,000 | -26.8% | 50,300 | -33.3% | 0.01% | -33.3% |
| Q1 2015 | $9,396,000 | +55.6% | 75,400 | +12.9% | 0.01% | +50.0% |
| Q4 2014 | $6,039,000 | +42.3% | 66,800 | +13.6% | 0.01% | +50.0% |
| Q3 2014 | $4,243,000 | -53.5% | 58,800 | -59.9% | 0.00% | -60.0% |
| Q2 2014 | $9,126,000 | +255.8% | 146,700 | +290.2% | 0.01% | +233.3% |
| Q1 2014 | $2,565,000 | -25.3% | 37,600 | -23.1% | 0.00% | -25.0% |
| Q4 2013 | $3,436,000 | +98.3% | 48,900 | +103.8% | 0.00% | +33.3% |
| Q3 2013 | $1,733,000 | -7.6% | 24,000 | -28.6% | 0.00% | 0.0% |
| Q2 2013 | $1,875,000 | – | 33,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 2,027 | $17,774,000 | 0.02% |
| Hudson Bay Capital Management LP | 40,000 | $3,508,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 103,800 | $9,102,000 | 0.02% |
| IMC-Chicago, LLC | 64,200 | $5,630,000 | 0.01% |
| JPMORGAN CHASE & CO | 353,400 | $30,990,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |